Keeping Track: Approvals For Polivy, Keytruda, FDA Applause For Biosimilars

 
• By Bridget Silverman

The latest drug development news and highlights from our US FDA Performance Tracker.

Keeping Track Feature image
Genentech, Merck & Co., Xeris and Amgen/Allergan are in Keeping Track's spotlight this week.

More from Approvals

More from Product Reviews